BR112019017049A2 - formulações de canabinoides para o tratamento de acne - Google Patents
formulações de canabinoides para o tratamento de acne Download PDFInfo
- Publication number
- BR112019017049A2 BR112019017049A2 BR112019017049A BR112019017049A BR112019017049A2 BR 112019017049 A2 BR112019017049 A2 BR 112019017049A2 BR 112019017049 A BR112019017049 A BR 112019017049A BR 112019017049 A BR112019017049 A BR 112019017049A BR 112019017049 A2 BR112019017049 A2 BR 112019017049A2
- Authority
- BR
- Brazil
- Prior art keywords
- cbd
- day
- alcohol
- pharmaceutical composition
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762459313P | 2017-02-15 | 2017-02-15 | |
| AU2017900493A AU2017900493A0 (en) | 2017-02-15 | Formulations of Cannabinoids for the Treatment of Acne | |
| PCT/AU2018/050045 WO2018148786A1 (en) | 2017-02-15 | 2018-01-24 | Formulations of cannabinoids for the treatment of acne |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019017049A2 true BR112019017049A2 (pt) | 2020-04-14 |
Family
ID=67766784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019017049A BR112019017049A2 (pt) | 2017-02-15 | 2018-01-24 | formulações de canabinoides para o tratamento de acne |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220323401A1 (enExample) |
| EP (1) | EP3582770A4 (enExample) |
| JP (2) | JP2020508992A (enExample) |
| CN (1) | CN110769819A (enExample) |
| AU (1) | AU2018221881B2 (enExample) |
| BR (1) | BR112019017049A2 (enExample) |
| CA (1) | CA3053503C (enExample) |
| IL (1) | IL268728B2 (enExample) |
| NZ (1) | NZ756307A (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019017049A2 (pt) * | 2017-02-15 | 2020-04-14 | Botanix Pharmaceuticals Ltd | formulações de canabinoides para o tratamento de acne |
| EP4111193A4 (en) * | 2020-02-25 | 2024-04-03 | Advanced Animal Diagnostics, Inc. | METHODS AND COMPOSITIONS FOR IDENTIFYING A SURVIVAL INDEX FOR AN ANIMAL |
| CN114073687A (zh) * | 2020-08-21 | 2022-02-22 | 四川大学华西医院 | 大麻二酚在制备防治玫瑰痤疮的药物中的用途 |
| CN113372196B (zh) * | 2021-07-02 | 2022-09-30 | 江南大学 | 8,9-二氢大麻二酚及其合成方法与应用 |
| JP7736306B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
| JP7736309B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
| JP7736310B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
| JP7736308B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0104268D0 (en) * | 2001-02-21 | 2001-04-11 | Unilever Plc | Antiperspirant or deodorant compositions |
| DE60228713D1 (de) * | 2001-07-18 | 2008-10-16 | Unilever Nv | Zusammensetzungen für die behandlung von haaren und/oder kopfhaut |
| WO2008024408A2 (en) * | 2006-08-22 | 2008-02-28 | Theraquest Biosciences, Inc. | Pharmaceutical formulations of cannabinoids for application to the skin and method of use |
| WO2009090495A2 (en) * | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| EP2424525A1 (en) * | 2009-04-28 | 2012-03-07 | AllTranz Inc. | Formulations of cannabidiol and methods of using the same |
| HUE026929T2 (en) * | 2010-10-19 | 2016-08-29 | Parenteral A S | A composition for the treatment of inflammatory diseases comprising boswellic acids and cannabidiol |
| US8758826B2 (en) * | 2011-07-05 | 2014-06-24 | Wet Inc. | Cannabinoid receptor binding agents, compositions, and methods |
| US20130184354A1 (en) * | 2012-01-13 | 2013-07-18 | Donna K. Jackson | Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management |
| WO2014074289A1 (en) * | 2012-11-06 | 2014-05-15 | Rochal Industries, Llp | Delivery of biologically-active agents using volatile, hydrophobic solvents |
| WO2014116653A1 (en) * | 2013-01-22 | 2014-07-31 | Coty Inc. | Topical formulations and methods for the use thereof |
| US20160022627A2 (en) * | 2014-04-18 | 2016-01-28 | Mary's Medicinals LLC | Transdermal cannabinoid patch |
| AU2016226267A1 (en) * | 2015-03-02 | 2017-09-28 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoids |
| EP3313394A4 (en) * | 2015-06-23 | 2019-02-27 | Axim Biotechnologies, Inc. | ANTIMICROBIAL COMPOSITIONS WITH CANNABINOIDS |
| BR112019017049A2 (pt) * | 2017-02-15 | 2020-04-14 | Botanix Pharmaceuticals Ltd | formulações de canabinoides para o tratamento de acne |
| CA3053500A1 (en) * | 2017-02-15 | 2018-08-23 | Botanix Pharmaceuticals Ltd | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases |
-
2018
- 2018-01-24 BR BR112019017049A patent/BR112019017049A2/pt not_active IP Right Cessation
- 2018-01-24 US US16/486,214 patent/US20220323401A1/en active Pending
- 2018-01-24 EP EP18754824.3A patent/EP3582770A4/en not_active Withdrawn
- 2018-01-24 AU AU2018221881A patent/AU2018221881B2/en not_active Ceased
- 2018-01-24 CN CN201880023591.0A patent/CN110769819A/zh active Pending
- 2018-01-24 JP JP2019544845A patent/JP2020508992A/ja not_active Withdrawn
- 2018-01-24 IL IL268728A patent/IL268728B2/en unknown
- 2018-01-24 NZ NZ756307A patent/NZ756307A/en not_active IP Right Cessation
- 2018-01-24 CA CA3053503A patent/CA3053503C/en active Active
-
2022
- 2022-10-17 JP JP2022166140A patent/JP2022185150A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020508992A (ja) | 2020-03-26 |
| JP2022185150A (ja) | 2022-12-13 |
| AU2018221881B2 (en) | 2023-09-14 |
| US20220323401A1 (en) | 2022-10-13 |
| CA3053503A1 (en) | 2018-08-23 |
| CA3053503C (en) | 2024-04-23 |
| AU2018221881A1 (en) | 2019-09-05 |
| CN110769819A (zh) | 2020-02-07 |
| EP3582770A1 (en) | 2019-12-25 |
| EP3582770A4 (en) | 2020-11-18 |
| IL268728A (en) | 2019-10-31 |
| IL268728B2 (en) | 2024-09-01 |
| IL268728B1 (en) | 2024-05-01 |
| NZ756307A (en) | 2023-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019017049A2 (pt) | formulações de canabinoides para o tratamento de acne | |
| CN110545807B (zh) | 用于治疗皮炎和炎性皮肤病的大麻素制剂 | |
| WO2018148786A1 (en) | Formulations of cannabinoids for the treatment of acne | |
| WO2018148785A1 (en) | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases | |
| JP2024016022A (ja) | 皮膚炎および炎症性皮膚状態のためのカンナビノイド投薬レジメン | |
| WO2018148787A1 (en) | Formulations of cannabinoids for the treatment of psoriasis | |
| Salau et al. | Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats | |
| JP2024012288A (ja) | ざ瘡のためのカンナビノイド投薬レジメン | |
| KR20130133295A (ko) | 시클릭 뎁시펩티드를 포함하는 현탁액 유형 국소 제제 | |
| Lein et al. | Dermal | |
| Bhaskar et al. | A review on: ointment and ointment bases | |
| US20190314325A1 (en) | Process and Method to Accelerate Cellular Regeneration, Healing and Wound Management | |
| US20110294896A1 (en) | Topical Treatment With Dapsone In G6PD-Deficient Patients | |
| Pan et al. | Oleogel-mediated Topical Administration of Roflumilast and Paclitaxel as a Synergistic Strategy to Combat Imiquimod-induced Psoriasis | |
| BR112019017011A2 (pt) | formulações de canabinoides para o tratamento de psoríase | |
| US20230025693A1 (en) | Deep penetrating topical cannabinoid compositions and methods for treating musculoskeletal inflammation and pain | |
| BR112019017045A2 (pt) | composições para tratar acne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICA??O DE DEVOLU??O DO PEDIDO EM FUN??O DA REVOGA??O DO ART. 229-C DA LEI N? 9.279, DE 1996, POR FOR?A DA LEI N? 14.195, DE 2021 |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2654 DE 16-11-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |